Home › Stocks › DMAC

DiaMedica Therapeutics Inc. (DMAC): insider buying, hedge funds & Congress trades

DiaMedica Therapeutics Inc. (DMAC): 5 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Dec 8, 2025Trill Ab
TenPercentOwner
1,061,277$7.19$7.6Mno history
Sep 4, 2025Stahlberg Jan
TenPercentOwner
1,000,000$5.96$6.0Mno history
Jul 25, 2025Jacinto Richard Ii
TenPercentOwner
400,000$3.50$1.4Mno history
Jul 25, 2025Von Koch Thomas
TenPercentOwner
2,857,142$3.50$10.0Mno history
Jul 25, 2025Stahlberg Jan
TenPercentOwner
1,542,857$3.50$5.4Mno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for DMAC

Free account. Know when insiders, famous funds or Congress trade it.

Start free